Literature DB >> 8834178

The DDX1 gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma.

L C Amler1, J Schürmann, M Schwab.   

Abstract

Human neuroblastoma cells frequently show amplification of the oncogene MYCN, which maps to 2p24. Previous studies have localized the DEAD box motif gene DDX1 to the same chromosome band and demonstrated coamplification of DDX1 and MYCN in two retinoblastoma cell lines. Recently, a high frequency of coamplification of DDX1 and MYCN has been shown in human neuroblastoma cells. We have determined the physical distance between the two genes by pulsed field gel electrophoresis in normal tissue and have found that DDX1 maps to a position at a maximum distance of 400 kbp 5' to MYCN. Two neuroblastoma cell lines with coamplification of DDX1/MYCN showed a similar topographic relationship of the two genes. In contrast, in two cell lines with high copy number, the DDX1 gene was not present in all amplified units recognized by MYCN and had changed its position in the amplified DNA relative to MYCN from 5' to 3', presumably by rearrangement during the amplification process. Our data show that the high frequency of DDX1 coamplification is due to its close physical distance to MYCN. Although amplification has resulted in an elevated expression of DDX1 the significance of overexpression for neuroblastoma remains unclear.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8834178     DOI: 10.1002/(SICI)1098-2264(199602)15:2<134::AID-GCC9>3.0.CO;2-4

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  Association of human DEAD box protein DDX1 with a cleavage stimulation factor involved in 3'-end processing of pre-MRNA.

Authors:  S Bléoo; X Sun; M J Hendzel; J M Rowe; M Packer; R Godbout
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

2.  Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma.

Authors:  A Pandita; M Zielenska; P Thorner; J Bayani; R Godbout; M Greenberg; J A Squire
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

3.  The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo.

Authors:  Adam J Linley; Morgan G Mathieu; Amanda K Miles; Robert C Rees; Stephanie E B McArdle; Tarik Regad
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

4.  Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress.

Authors:  Zheming Lu; Lei Zhou; Patrick Killela; Ahmed B Rasheed; Chunhui Di; William E Poe; Roger E McLendon; Darell D Bigner; Christopher Nicchitta; Hai Yan
Journal:  Cancer Res       Date:  2009-11-17       Impact factor: 12.701

5.  Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status.

Authors:  C L Cunsolo; M P Bicocchi; A R Petti; G P Tonini
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

Review 6.  Molecular Genetics in Neuroblastoma Prognosis.

Authors:  Margherita Lerone; Marzia Ognibene; Annalisa Pezzolo; Giuseppe Martucciello; Federico Zara; Martina Morini; Katia Mazzocco
Journal:  Children (Basel)       Date:  2021-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.